Clioquinol Synergistically Augments Rescue by Zinc Supplementation in a Mouse Model of Acrodermatitis Enteropathica

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Geiser, Jim ^a   de Lisle, Robert C ^a   Finkelstein, David ^b   Adlard, Paul A ^b   Bush, Ashley I ^b   Andrews, Glen K ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

8 QUINOLINOL; CLIOQUINOL; DRINKING WATER; UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER; ZIP4 PROTEIN;

ACRODERMATITIS ENTEROPATHICA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CONTROLLED STUDY; DIET THERAPY; DISEASE MODEL; GENE INACTIVATION; GROWTH ACCELERATION; INTESTINAL SECRETION; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE INJURY; INTESTINE STEM CELL; LETHALITY; LIVER METABOLISM; LONGEVITY; MOUSE; NONHUMAN; PHENOTYPE; SECRETORY CELL; STEM CELL; SUPPLEMENTATION; TREATMENT DURATION; WEIGHT REDUCTION; ZINC DEFICIENCY; ZINC SUPPLEMENTATION; ZIP4 GENE;

ACRODERMATITIS; ANIMALS; CATION TRANSPORT PROTEINS; CLIOQUINOL; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; HUMANS; INTESTINES; LIVER; MICE; MICE, KNOCKOUT; ZINC;

EID: 84883138793     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072543     Document Type: Article

References (68)

1. Prasad AS, (2012) Discovery of human zinc deficiency: 50 years later. J Trace Elem Med Biol 26: 66-69.
2. Neggers YH, Cutter GR, Acton RT, Alvarez JO, Bonner JL et al, (1990) A positive association between maternal serum zinc concentration and birth weight. Am J Clin Nutr 51: 678-684.
3. Tamura T, Goldenberg RL, Johnston KE, DuBard M, (2000) Maternal plasma zinc concentrations and pregnancy outcome. Am J Clin Nutr 71: 109-113.
4. Hambidge KM, Krebs NF, (2003) Zinc, low birth weight, and breastfeeding. Pediatrics 112: 1419-1420.
5. Bloxam DL, Bax CMR, (1996) Zinc deficiency and abnormal fetal development: Assessment of maternal or fetal zinc status. Am J Obstet Gynecol 175: 1078.
6. Andrews RCR, (1992) Diabetes and schizophrenia: Genes or zinc deficiency. Lancet 340: 1160.
7. Black MM, (1998) Zinc deficiency and child development. Am J Clin Nutr 68Suppl.: 464S-469S.
8. Salgueiro MJ, Weill R, Zubillaga M, Lysionek A, Caro R, et al. (2004) Zinc deficiency and growth- Current concepts in relationship to two important points: Intellectual and sexual development. Biol Trace Elem Res 99: 49-69.
9. Prasad AS, (2007) Zinc: mechanisms of host defense. J Nutr 137: 1345-1349.
10. Black RE, (2003) Zinc deficiency, infectious disease and mortality in the developing world. J Nutr 133: 1485S-1489S.
11. Vallee BL, Auld DS, (1990) Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry 29: 5647-5659.
12. Berg JM, Shi YG, (1996) The galvanization of biology: A growing appreciation for the roles of zinc. Science 271: 1081-1085.
13. Krishna SS, Majumdar I, Grishin NV, (2003) Structural classification of zinc fingers. Nucleic Acids Res 31: 532-550.
14. Kelleher SL, Lonnerdal B, (2006) Zinc Supplementation Reduces Iron Absorption through Age-Dependent Changes in Small Intestine Iron Transporter Expression in Suckling Rat Pups. J Nutr 136: 1185-1191.
15. Doherty K, Connor M, Cruickshank R, (2011) Zinc-containing denture adhesive: a potential source of excess zinc resulting in copper deficiency myelopathy. Br Dent J 210: 523-525.
16. Afrin LB, (2010) Fatal copper deficiency from excessive use of zinc-based denture adhesive. Am J Med Sci 340: 164-168.
17. Yang Y, Jing XP, Zhang SP, Gu RX, Tang FX, et al. (2013) High dose zinc supplementation induces hippocampal zinc deficiency and memory impairment with inhibition of BDNF signaling. PLoS One 8: e55384.
18. Seok SH, Cho WS, Park JS, Na Y, Jang A, et al. (2013) Rat pancreatitis produced by 13-week administration of zinc oxide nanoparticles: biopersistence of nanoparticles and possible solutions. J Appl Toxicol e-pub; In Press.
19. Blundell R, Adam F, (2013) Haemolytic anaemia and acute pancreatitis associated with zinc toxicosis in a dog. Vet Rec 172: 17.
20. Dhawan SS, Ryder KM, Pritchard E, (2008) Massive penny ingestion: the loot with local and systemic effects. J Emerg Med 35: 33-37.
21. Lonnerdal B, (2000) Dietary factors influencing zinc absorption. J Nutr 130: 1378S-1383S.
22. Prasad AS, (1984) Discovery and importance of zinc in human nutrition. Fed Proc 43: 2829-2834.
23. Chowanadisai W, Lonnerdal B, Kelleher SL, (2006) Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency. J Biol Chem 281: 39699-39707.
24. Fukada T, Civic N, Furuichi T, Shimoda S, Mishima K, et al. (2008) The zinc transporter SLC39A13/ZIP13 is required for connective tissue development; its involvement in BMP/TGF-beta signaling pathways. PLoS ONE 3: e3642.
25. Atherton DJ, Muller DP, Aggett PJ, Harries JT, (1979) A defect in zinc uptake by jejunal biopsies in acrodermatitis enteropathica. Clin Sci (Lond) 56: 505-507.
26. Geiser J, Venken KJ, De Lisle RC, Andrews GK, (2012) A Mouse Model of Acrodermatitis Enteropathica: Loss of Intestine Zinc Transporter ZIP4 (Slc39a4) Disrupts the Stem Cell Niche and Intestine Integrity. PLoS Genet 8: e1002766.
27. Moynahan EJ, (1974) Letter: Acrodermatitis enteropathica: a lethal inherited human zinc- deficiency disorder. Lancet 2: 399-400.
28. Kilic M, Taskesen M, Coskun T, Gurakan F, Tokatli A, et al. (2012) A Zinc Sulphate-Resistant Acrodermatitis Enteropathica Patient with a Novel Mutation in SLC39A4 Gene. JIMD Rep 2: 25-28.
29. Adlard PA, Bush AI, (2012) Metal chaperones: a holistic approach to the treatment of Alzheimer's disease. Front Psychiatry 3: 1-5.
30. Bareggi SR, Cornelli U, (2012) Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci Ther 18: 41-46.
31. Neldner KH, Hagler L, Wise WR, Stifel FB, Lufkin EG, et al. (1974) Acrodermatitis enteropathica. A clinical and biochemical survey. Arch Dermatol 110: 711-721.
32. Bloom D, Sobel N, (1955) Acrodermatitis enteropathica successfully treated with diodoquin. J Invest Dermatol 24: 167-177.
33. Sundal A, (1957) Enteropathic acrodermatitis (Danbolt-Closs) and diodoquin treatment. Ann Paediatr Fenn 3: 486-493.
34. Sturtevant FM, (1980) Zinc deficiency, acrodermatitis enteropathica, optic atrophy, subacute myelo-optic neuropathy, and 5,7-dihalo-8-quinolinols. Pediatrics 65: 610-613.
35. Aggett PJ, Delves HT, Harries JT, Bangham AD, (1979) The possible role of diodoquin as a zinc ionophore in the treatment of acrodermatitis enteropathica. Biochem Biophys Res Commun 87: 513-517.
36. Jackson MJ, (1977) Zinc and di-iodohydroxyquinoline therapy in acrodermatitis enteropathica. J Clin Pathol 30: 284-287.
37. Schafer S, Pajonk FG, Multhaup G, Bayer TA, (2007) Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels. J Mol Med (Berl) 85: 405-413.
38. Tardiff DF, Tucci ML, Caldwell KA, Caldwell GA, Lindquist S, (2012) Different 8-hydroxyquinolines protect models of TDP-43 protein, alpha-synuclein, and polyglutamine proteotoxicity through distinct mechanisms. J Biol Chem 287: 4107-4120.
39. Ryu JM, Lee MY, Yun SP, Han HJ, (2009) Zinc chloride stimulates DNA synthesis of mouse embryonic stem cells: involvement of PI3K/Akt, MAPKs, and mTOR. J Cell Physiol 218: 558-567.
40. Corniola RS, Tassabehji NM, Hare J, Sharma G, Levenson CW, (2008) Zinc deficiency impairs neuronal precursor cell proliferation and induces apoptosis via p53-mediated mechanisms. Brain Res 1237: 52-61.
41. Weaver BP, Zhang Y, Hiscox S, Guo GL, Apte U, et al. (2010) Zip4 (Slc39a4) expression is activated in hepatocellular carcinomas and functions to repress apoptosis, enhance cell cycle and increase migration. PLoS ONE 5: e13158.
42. Li M, Zhang Y, Liu Z, Bharadwaj U, Wang H, et al. (2007) Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A 104: 18636-18641.
43. Zhang Y, Bharadwaj U, Logsdon CD, Chen C, Yao Q, et al. (2010) ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB. Clin Cancer Res 16: 1423-1430.
44. Tang Z, Sahu SN, Khadeer MA, Bai G, Franklin RB, et al. (2006) Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells. Bone 38: 181-198.
45. Yamasaki S, Sakata-Sogawa K, Hasegawa A, Suzuki T, Kabu K, et al. (2007) Zinc is a novel intracellular second messenger. J Cell Biol 177: 637-645.
46. Fukada T, Yamasaki S, Nishida K, Murakami M, Hirano T, (2011) Zinc homeostasis and signaling in health and diseases: Zinc signaling. J Biol Inorg Chem 16: 1123-1134.
47. Sharir H, Zinger A, Nevo A, Sekler I, Hershfinkel M, (2010) Zinc released from injured cells is acting via the Zn2+-sensing receptor, ZnR, to trigger signaling leading to epithelial repair. J Biol Chem 285: 26097-26106.
48. Aydemir TB, Sitren HS, Cousins RJ, (2012) The zinc transporter Zip14 influences c-Met phosphorylation and hepatocyte proliferation during liver regeneration in mice. Gastroenterology 142: 1536-1546.
49. Haase H, Maret W, (2003) Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp Cell Res 291: 289-298.
50. Hogstrand C, Kille P, Nicholson RI, Taylor KM, (2009) Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation. Trends Mol Med 15: 101-111.
51. Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, et al. (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59: 43-55.
52. Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, et al. (2008) Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol 7: 779-786.
53. Faux NG, Ritchie CW, Gunn A, Rembach A, Tsatsanis A, et al. (2010) PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. J Alzheimers Dis 20: 509-516.
54. Crouch PJ, Savva MS, Hung LW, Donnelly PS, Mot AI, et al. (2011) The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation and GSK3 phosphorylation via a metal chaperone activity. J Neurochem 119: 220-230.
55. Opazo C, Luza S, Villemagne VL, Volitakis I, Rowe C, et al. (2006) Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease. Aging Cell 5: 69-79.
56. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, et al. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30: 665-676.
57. Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, et al. (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59: 43-55.
58. Ding WQ, Liu B, Vaught JL, Yamauchi H, Lind SE, (2005) Anticancer activity of the antibiotic clioquinol. Cancer Res 65: 3389-3395.
59. Arbiser JL, Kraeft SK, van Leeuwen R, Hurwitz SJ, Selig M, et al. (1998) Clioquinol-zinc chelate: a candidate causative agent of subacute myelo-optic neuropathy. Mol Med 4: 665-670.
60. Yu H, Zhou Y, Lind SE, Ding WQ, (2009) Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J 417: 133-139.
61. Nitzan YB, Sekler I, Frederickson CJ, Coulter DA, Balaji RV, et al. (2003) Clioquinol effects on tissue chelatable zinc in mice. J Mol Med (Berl) 81: 637-644.
62. Weismann K, Knudsen L, (1978) Effects of penicillamine and hydroxyquinoline on absorption of orally ingested 65zinc in the rat. J Invest Dermatol 71: 242-244.
63. Dufner-Beattie J, Weaver BP, Geiser J, Bilgen M, Larson M, et al. (2007) The mouse acrodermatitis gene Slc39a4 (ZIP4) is essential for development and heterozygosity causes hypersensitivity to zinc deficiency. Hum Mol Genet 16: 1391-1399.
64. el Marjou F, Janssen KP, Chang BH, Li M, Hindie V, et al. (2004) Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39: 186-193.
65. Dufner-Beattie J, Kuo YM, Gitschier J, Andrews GK, (2004) The adaptive response to dietary zinc in mice involves the differential cellular localization and zinc-regulation of the zinc transporters ZIP4 and ZIP5. J Biol Chem 279: 49082-49090.
66. Baxter I, Ouzzani M, Orcun S, Kennedy B, Jandhyala SS, et al. (2007) Purdue ionomics information management system. An integrated functional genomics platform. Plant Physiol 143: 600-611.
67. Ferrada E, Arancibia V, Loeb B, Norambuena E, Olea-Azar C, et al. (2007) Stoichiometry and conditional stability constants of Cu(II) or Zn(II) clioquinol complexes; implications for Alzheimer's and Huntington's disease therapy. Neurotoxicology 28: 445-449.
68. Di Vaira M, Bazzicalupi C, Orioli P, Messori L, Bruni B, et al. (2004) Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes. Inorg Chem 43: 3795-3797.